Earnings Releases·Nov 9, 2026, 4:06 PM ET

LifeVantage — First Quarter Fiscal 2027 Earnings Summary

Revenue declined 22.0% year-over-year to $37.1 million, driven by a 19.0% drop in active accounts and lower sales of the MindBody GLP-1 System®, while net loss per diluted share widened to $0.02 from a $0.17 profit a year ago.
Adjusted EBITDA fell to $1.9 million (5.2% of revenue) from $3.9 million (8.2% of revenue), with gross profit margin contracting to 75.4% due to a $1.0 million inventory obsolescence allowance.
Cash flow from operations improved to $0.5 million generated versus $2.3 million used in the prior year, leaving $13.7 million in cash and cash equivalents with no debt outstanding.
The company repurchased no shares during the quarter, though $58.5 million remains available under its $60 million share repurchase program.